Expert Consulting in AAV Gene Therapy Solutions
Specializing in innovative AAV gene therapy, AAVion offers tailored expertise in gene delivery, expression, and comprehensive support from experimental design through final analysis, guiding you toward a successful Investigational New Drug (IND) application.
Let’s Collaborate
About
AAVion LLC is a Maryland-based consulting company specializing in Adeno-Associated Virus (AAV) biology and gene therapy. Founded and led by Dr. Prasad Konkalmatt.
We offer personalized expertise in AAV vector design, promoter and capsid engineering, and experimental designs for in-vitro and in-vivo preclinical studies to support gene therapy research and development.
The name AAVion is inspired by avion (French/Spanish for airplane) and highlights our expertise in AAV gene therapy technologies.
Who we are
Meet Dr. Prasad Konkalmatt, PhD
A Legacy of Innovation in Gene Therapy
Dr. Konkalmatt brings decades of experience in AAV biology, with a distinguished career spanning academic research at leading institutions as well as biopharmaceutical innovation in the gene therapy industry. As a pioneer in the field, Dr. Konkalmatt has contributed significantly to advancing AAV technology for therapeutic applications.
Our Clients
Estuary Biotherapeutics, Inc.
Private Gene Therapy Company, Currently in Stealth
Services
AAVion LLC provides specialized consulting services in AAV gene therapy, tailored to the needs of biotechnology companies, biopharma innovators, and academic researchers. We take a customized, project-focused approach to ensure that each client’s goals are met efficiently and effectively.
Our areas of expertise include:
Preclinical Study Guidance: Strategic planning and experimental design for in vivo and in vitro studies, ensuring robust methods to achieve specific objectives.
AAV Vector Design: Providing guidance on designing AAV vectors tailored for both preclinical and clinical applications.
Promoter Engineering: Development of custom promoters to enable efficient and targeted gene expression in specific cell types.
Capsid Engineering: Development of novel AAV capsids through directed evolution, leveraging capsid library construction and advanced screening strategies to optimize targeting efficiency and specificity.
Streamlined vector design for optimized gene expression and robust experimental strategies to support IND-enabling studies and accelerate the translation of therapies from research to clinical application.
Begin Your Journey
Contact:
Email: pkonkalmatt@aavionsol.com
Phone: +1-434-245-1635